Skip to Main Content

Paper Details

Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.
Liver Int
3
2022
ABT, ABT-199, Bcl-2, Bcl-2 protein, Bcl-2 proteins, Bcl-x, CCA, CCA cell lines, CCA cells, Intrahepatic, perihilar, and distal cholangiocarcinoma, Mcl-1, RNA, S63845, Wehi-539, anti-apoptotic Bcl-2 proteins, cancer, cell lines, cholangiocarcinoma, cholangiocytes, dCCA, human, iCCA, malignant tumours, pCCA, pan-cancer, patient
Author NameAffiliation
Albrecht StenzingerInstitute for Pathology, University Hospital Heidelberg
Frederick Klauschen
Frederick KlauschenInstitute of Pathology, Charite University Medicine Berlin
Benedikt BrorsNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Benedikt BrorsNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Daniel H??bschmann
Daniel H??bschmannHeidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM)
Daniel H??bschmannNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Daniel H??bschmann
Daniel H??bschmannNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Daniel H??bschmannHeidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM)
Sebastian UhrigNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Peter HorakNCT Heidelberg and German Cancer Research Center (DKFZ)
Peter Horak
Simon KreutzfeldtNCT Heidelberg and German Cancer Research Center (DKFZ)
Simon Kreutzfeldt
Peter SchirmacherInstitute for Pathology, University Hospital Heidelberg
Peter SchirmacherLiver Cancer Center Heidelberg, University Hospital Heidelberg
Stephanie RoesslerInstitute for Pathology, University Hospital Heidelberg
Stephanie RoesslerLiver Cancer Center Heidelberg, University Hospital Heidelberg
Stefan Fr??hlingNCT Heidelberg and German Cancer Research Center (DKFZ)
Stefan Fr??hling
  • 1 - 22

Datasets

Release 1.2